<DOC>
	<DOCNO>NCT00397592</DOCNO>
	<brief_summary>To assess effect short-term low-dose growth hormone therapy mobilization endothelial progenitor cell bone marrow within group healthy adult .</brief_summary>
	<brief_title>Growth Hormone 's Effect Endothelial Progenitor Cells</brief_title>
	<detailed_description>We propose pilot study assess effect administration recombinant human growth hormone number endothelial progenitor cell ( EPC ’ ) peripheral circulation . An increase number EPC ’ view beneficial , postulate provide endogenous repair mechanism counteract endothelial injury . Additionally , reduce number EPC ’ find independently predict atherosclerotic disease progression . Mechanisms propose enhance number circulate EPC ’ function include increase proliferation , mobilization bone marrow , prevention EPC apoptosis . Thus , pharmacologic manipulation number EPC ’ peripheral circulation could potentially serve mechanism endothelial function , thus vascular health , may improve .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Adults age 18 thru 65 Serum IGF1 low half age genderspecific normal range time screen visit Systemic hypertension , define current BP &gt; 140/90 screen visit , take antihypertensive therapy . Diabetes mellitus , define know diagnosis Fasting Blood Glucose &gt; 126 time screen visit . Women pregnant nursing , confirm history seum betahCG time screen visit . Women take exogenous oral estrogen kind . Personal history active cancer recurrence within past 10 year , exception nonmelanoma skin cancer . Personal history untreated benign intracranial neoplasm . Initiation statin therapy course study . A serum IGF1 level age genderspecific normal range time screen visit . Renal insufficiency , define GFR &lt; 60 mls/min/1.73 m2 upon Renal Function panel time screen visit . Hepatic insufficiency , define AST and/or ALT &gt; twice upper limit normal time screen visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Growth Hormone</keyword>
	<keyword>Cardiovascular System</keyword>
	<keyword>Endothelial Progenitor Cells</keyword>
</DOC>